Our Board of Directors bring their expertise and contributions in consumer health and technology to the Tivic Health team, as we scale up commercial operations and develop new bioelectronics therapies.
Jennifer is a consummate hi-tech business developer with a history of developing markets from new technologies such as Thin Film Electronics ($480M market cap in 5 yrs) with Xerox PARC. With over 20 years at Xerox PARC, she held multiple go-to-market roles and marketed multiple award-winning products. MBA, Santa Clara University. Jennifer has been featured in Authority Magazine and Thrive Global as a female leader who is shaking up things in the industry.
Sheryle is Professor of Entrepreneurship, Hult International Business School. She is an experienced public company CEO, international Board Member and serial entrepreneur. As CEO and Chairman of Scientific Learning Corporation, a neuroscience technology company, she built the company from pre-product to a highly successful IPO. Previously, she was vice president at Merrill Lynch Capital Markets, and a senior executive at Home Box Office and Rockefeller and Co. Two Stanford Business School cases have been written about her career, and she has been recognized as one of the most influential female Harvard Business School graduates.
Karen Drexler has served as a director on our board since July 16, 2019. Ms. Drexler is a serial entrepreneur with expertise in the fields of digital health, medical devices and diagnostics. From September 2014 to June 2020 she served as board member of, and from June 2016 until June 2020, she was the Chief Executive Officer of, Sandstone Diagnostics, Inc., a private company developing instruments and consumables for point-of-care medical testing. Ms. Drexler also serves on the boards of ResMed (NYSE: RSMD), OutSet Medical (NASDAQ: OM), EBR Systems (ASX: EBR), VIDA Health, a leading company in Al-powered lung intelligence solutions and analytics, and Huma.ai, a medical intelligence company. From 2011 to 2017, she served as Chair of the board of Hygieia, Inc., a digital insulin therapy company, where she remains involved as an advisor to the chief executive officer. She also acts as a senior strategic advisor for other early-stage companies and spent 11 years on the board of the Keller Center for Innovation in Engineering Education at Princeton University. Ms. Drexler has served on numerous private company boards in the fields of diagnostics, medical devices, and digital health. She is an active mentor and advisor with Astia, a global nonprofit that supports high-potential female founders. She is a founding member of Astia Angels, a network of individual investors who fund such founders, and a lead mentor with StartX, the Stanford University incubator. She is also on the Life Science and Women’s Health Councils for Springboard, an accelerator for women-led technology-oriented companies. Through her work with Astia, Springboard, and StartX, she interacts with many promising young medtech companies. Ms. Drexler was a founder, president, and Chief Executive Officer of Amira Medical Inc., a private company focused on minimally invasive glucose monitoring technology, from 1996 until it was sold to Roche Holding AG in 2001. Before joining Amira Medical, she held management roles at LifeScan and played a key role in its sale to Johnson & Johnson (NYSE: JNJ). Ms. Drexler graduated magna cum laude with a Bachelor of Science in Chemical Engineering from Princeton University and earned a Master of Business Administration with honors from the Stanford University Graduate School of Business.
Dean brings deep industry experience in allergy and asthma to the Board. He has previously served as CEO of Spirosure, a FeNO detection company for asthma diagnostics. He has also previously served as head of global marketing for Johnson & Johnson's Animas Corporation within their medical device & diagnostics division. He was head of strategy for Pfizer Pharmaceuticals U.S. Cardiovascular Unit, a division with about $7 billion in annual revenues. Zikria brings experience in strategic planning, scenario planning and analysis, and mergers and acquisitions, including sourcing, transactions and integration.